Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04491942
Title Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung small cell carcinoma

endometrial cancer

lung non-small cell carcinoma

stomach cancer

cervical cancer

transitional cell carcinoma

esophageal cancer

triple-receptor negative breast cancer

malignant pleural mesothelioma

ovarian cancer

Advanced Solid Tumor

penile cancer

biliary tract cancer

head and neck cancer

Therapies

BAY1895344 + Cisplatin

BAY1895344 + Cisplatin + Gemcitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.